Clinical Trial Update: Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin [Phase 4]

View source ↗

Summary

Phase 4 trial of Panax Notoginseng Saponin for hypertensive intracerebral hemorrhage completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Panax Notoginseng Saponin (Panax notoginseng saponin)

Snippet

Sponsor: The First People's Hospital of Jingzhou | Conditions: Hematoma Absorption and Neurological Function Recovery | Phase 4 | Status: COMPLETED